Given that PI3K/AKT activation is required for HCC progression and metastasis [27, 28], we wondered whether LZTS2 might be involved in these biological processes by modulating the PI3K/AKT pathway in HCC. The gene discussed is AKT1; the disease is hepatocellular carcinoma.